# Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Cold

NDC: 58602-816
Generic name: Naproxen Sodium and Pseudoephedrine Hydrochloride
Labeler / Manufacturer: Aurohealth LLC
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20220601

FDA application: ANDA211360

## Active ingredients

- NAPROXEN SODIUM: 220 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE: 120 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58602-816"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58602-816
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=638a9664-4129-46fd-9ba1-d660a7366c9f